Laborex Uganda Limited Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: Laborex Uganda Limited Pharmaceutical Import Records from India — 4 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Laborex Uganda Limited — Pharmaceutical Importer Profile (2026) | 4 Products, $3.8M Trade | TransData Nexus

Laborex Uganda Limited

Pharmaceutical Importer · Kenya · Advanced Antibiotics Focus · $3.8M Total Trade · DGFT Verified

Laborex Uganda Limited is a pharmaceutical importer based in Kenya with a total trade value of $3.8M across 4 products in 3 therapeutic categories. Based on 156 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Laborex Uganda Limited sources from 1 verified Indian supplier, with Micro Labs Limited accounting for 100.0% of imports.

Laborex Uganda Limited — Import Portfolio & Supplier Network

Laborex Uganda Limited import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Laborex Uganda Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$6.8M	421	100.0%

Laborex Uganda Limited sources from 1 verified Indian supplier across 357 distinct formulations. The sourcing is highly concentrated — Micro Labs Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Laborex Uganda Limited Import?

Formulation	Value	Ships
Gramocef o 400 ( (cefixime 400MG	$74.0K	2
Ornilox ( (ornidazole 500MG & ofloxacin200mg tablets) ) ( 1x10's )	$66.3K	2
Bactoclav 228.5 dry syrup ( (amoxycillin+ clavulanate potassium for-oral ) ( 100ML ) ( qty- 49452.000 )	$64.6K	3
Levobact infusion ( (levofloxacin	$63.5K	2
Levobact infusion ( (levofloxacin 500MG	$59.0K	2
Bactoclav 625 (amoxycillin 500MG+potassium clavulanate 125MG BP tablets) ( 2x10s) ( qty- 38368	$55.9K	3
Co-trimoxazole ( (co-trimoxazole tabletsbp 960MG) ) ( 10x10s ) ( qty- 29130.000)	$51.7K	3
Levobact-750 ( (levofloxacin tablets 750MG ih) ) ( 1x10s ) ( qty- 11200.000	$50.7K	3
Ornilox (ofloxacin + ornidazole tablets)	$50.0K	1
Bactoclav 625 ( (amoxicillin 500MG +	$50.0K	1
Esofag kit ( (clarithromycin USP 500MG	$50.0K	1
Gramocef-o-200 ( (cefixime 200MG	$50.0K	1
Esofag kit ( (amloxicillin 1MG tablets	$50.0K	1
Levobact 750 ( (levofloxacin 750MG ih	$50.0K	1
Levobact-750 ( (levofloxacin 750MG ih	$50.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cefixime	Advanced Antibiotics	$1.7M	66	1.0%	13
2	Levofloxacin	Antibiotics	$1.3M	60	1.7%	8
3	Ornidazole	Advanced Antibiotics	$714.6K	20	4.0%	3
4	Domperidone	Gastrointestinal	$205.7K	10	0.7%	19

Laborex Uganda Limited imports 4 pharmaceutical products across 3 categories into Kenya totaling $3.8M.

Laborex Uganda Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Laborex Uganda Limited is a pharmaceutical importer and distributor headquartered in Kampala, Uganda. As a subsidiary of the CFAO Group, a leader in specialized distribution across Africa and French overseas territories, Laborex Uganda Limited plays a pivotal role in the pharmaceutical supply chain within the region.

The company imports a diverse range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. These products are distributed throughout Uganda, ensuring the availability of essential medications across the country. Laborex Uganda Limited's strategic location in Kampala facilitates efficient logistics and distribution, enabling timely delivery to various healthcare facilities and pharmacies.

2Distribution Network

Laborex Uganda Limited operates a state-of-the-art medical storage and distribution facility located in the Namanve Industrial Park, Kampala. This facility, covering approximately 2,000 square meters, was designed to integrate local building materials with advanced pharmaceutical planning, reflecting the company's commitment to quality and efficiency.

The warehouse's strategic position within the industrial park enhances logistical capabilities, allowing for streamlined operations and rapid distribution across Uganda. This centralized distribution hub ensures that Laborex Uganda Limited can effectively manage inventory and meet the demands of the Ugandan pharmaceutical market.

3Industry Role

Laborex Uganda Limited serves as a primary wholesaler and distributor in Uganda's pharmaceutical supply chain. By importing a wide array of finished pharmaceutical formulations from international suppliers, particularly from India, the company ensures a steady supply of essential medications to the Ugandan market. This role is crucial in maintaining the availability of quality pharmaceuticals across the country.

The company's operations are characterized by a focus on quality assurance and regulatory compliance, ensuring that all imported products meet the standards set by Ugandan health authorities. Laborex Uganda Limited's position as a key wholesaler underscores its significant contribution to the healthcare sector in Uganda.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Laborex Uganda Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Laborex Uganda Limited's sourcing strategy is heavily concentrated on a single supplier, Micro Labs Limited, which accounts for 100% of its pharmaceutical imports from India. This exclusive relationship indicates a deep integration between the two entities, potentially leading to favorable terms and streamlined supply chain operations.

However, this high level of supplier concentration also introduces risks. Any disruptions affecting Micro Labs Limited—such as production issues, regulatory challenges, or logistical problems—could significantly impact Laborex Uganda Limited's ability to meet market demand. To mitigate such risks, it would be prudent for Laborex Uganda Limited to consider diversifying its supplier base, thereby enhancing supply chain resilience and reducing dependency on a single source.

2Supply Chain Resilience

The resilience of Laborex Uganda Limited's supply chain is closely tied to its exclusive partnership with Micro Labs Limited. While this relationship may offer operational efficiencies, it also exposes the company to potential vulnerabilities. For instance, any disruptions in Micro Labs Limited's operations could directly affect Laborex Uganda Limited's ability to supply pharmaceuticals to the Ugandan market.

To bolster supply chain resilience, Laborex Uganda Limited should explore establishing relationships with additional suppliers. This strategy would provide alternative sources for pharmaceutical products, ensuring continuity of supply in the event of disruptions. Additionally, diversifying suppliers can lead to competitive pricing and access to a broader range of products, enhancing the company's market position.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Uganda, the National Drug Authority (NDA) is the primary regulatory body responsible for overseeing the importation, distribution, and sale of pharmaceutical products. The NDA ensures that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are permitted for use in the country.

The regulatory framework governing pharmaceutical imports includes stringent requirements for product registration, quality assurance, and compliance with international standards. Pharmaceutical companies must adhere to these regulations to ensure that their products are authorized for sale in Uganda.

2Import Licensing & GMP

Import licensing in Uganda requires pharmaceutical companies to obtain approval from the National Drug Authority (NDA) before importing any pharmaceutical products. This process involves submitting detailed documentation, including product specifications, manufacturing processes, and evidence of Good Manufacturing Practice (GMP) compliance.

The NDA recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Pharmaceutical companies seeking to import products into Uganda must ensure that their manufacturing facilities hold valid GMP certifications from these recognized organizations to facilitate the importation process.

Laborex Uganda Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Laborex Uganda Limited's focus on importing advanced antibiotics, general antibiotics, and gastrointestinal medications aligns with the prevalent health challenges in Uganda. The high import values of cefixime, levofloxacin, and ornidazole indicate a significant demand for these therapeutic categories.

The company's product strategy is driven by the need to address common infectious diseases and gastrointestinal disorders in the region. By focusing on these areas, Laborex Uganda Limited ensures that essential medications are readily available to meet the healthcare needs of the Ugandan population.

2Sourcing Profile

Laborex Uganda Limited's sourcing strategy is centered on importing generic pharmaceutical formulations from India, with a particular emphasis on antibiotics and gastrointestinal medications. This approach allows the company to provide cost-effective solutions to the Ugandan market while maintaining a focus on quality.

India's well-established pharmaceutical industry, known for its adherence to international quality standards, makes it a reliable source for Laborex Uganda Limited's procurement needs. The company's sourcing profile reflects a strategic alignment with market demands and a commitment to ensuring the availability of essential medications in Uganda.

3Market Positioning

Seller's Guide — How to Become a Supplier to Laborex Uganda Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Ugandan market by partnering with Laborex Uganda Limited. The company's established distribution network and focus on high-demand therapeutic areas present a favorable environment for introducing additional products.

Potential gaps in Laborex Uganda Limited's current sourcing include a limited supplier base and a concentration on specific therapeutic categories. New suppliers can address these gaps by offering a broader range of products and diversifying the supplier base, thereby enhancing supply chain resilience and meeting a wider array of market needs.

2Requirements & Qualifications

Indian exporters seeking to supply Laborex Uganda Limited and the Ugandan market must ensure that their products are registered with the National Drug Authority (NDA) in Uganda. This involves providing comprehensive documentation, including product specifications, manufacturing processes, and evidence of Good Manufacturing Practice (GMP) compliance.

Additionally, exporters must adhere to

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Laborex Uganda Limited

What products does Laborex Uganda Limited import from India?

Laborex Uganda Limited imports 4 pharmaceutical products across 3 categories. Top imports: Cefixime ($1.7M), Levofloxacin ($1.3M), Ornidazole ($714.6K), Domperidone ($205.7K).

Who supplies pharmaceuticals to Laborex Uganda Limited from India?

Laborex Uganda Limited sources from 1 verified Indian suppliers. The primary supplier is Micro Labs Limited (100.0% of imports, $6.8M).

What is Laborex Uganda Limited's total pharmaceutical import value?

Laborex Uganda Limited's total pharmaceutical import value from India is $3.8M, based on 156 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Laborex Uganda Limited focus on?

Laborex Uganda Limited imports across 3 categories. The largest: Advanced Antibiotics (61.9%), Antibiotics (32.7%), Gastrointestinal (5.4%).

Get Full Laborex Uganda Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.